Cargando…
COVID-19, Clinical Trials, and QT-Prolonging Prophylactic Therapy in Healthy Subjects: First, Do No Harm
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
by the American College of Cardiology Foundation. Published by Elsevier.
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7213956/ https://www.ncbi.nlm.nih.gov/pubmed/32407770 http://dx.doi.org/10.1016/j.jacc.2020.05.008 |
| _version_ | 1783531888293445632 |
|---|---|
| author | Gollob, Michael H. |
| author_facet | Gollob, Michael H. |
| author_sort | Gollob, Michael H. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-7213956 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2020 |
| publisher | by the American College of Cardiology Foundation. Published by Elsevier. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-72139562020-05-12 COVID-19, Clinical Trials, and QT-Prolonging Prophylactic Therapy in Healthy Subjects: First, Do No Harm Gollob, Michael H. J Am Coll Cardiol Article by the American College of Cardiology Foundation. Published by Elsevier. 2020-06-30 2020-05-11 /pmc/articles/PMC7213956/ /pubmed/32407770 http://dx.doi.org/10.1016/j.jacc.2020.05.008 Text en © 2020 by the American College of Cardiology Foundation. Published by Elsevier. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Article Gollob, Michael H. COVID-19, Clinical Trials, and QT-Prolonging Prophylactic Therapy in Healthy Subjects: First, Do No Harm |
| title | COVID-19, Clinical Trials, and QT-Prolonging Prophylactic Therapy in Healthy Subjects: First, Do No Harm |
| title_full | COVID-19, Clinical Trials, and QT-Prolonging Prophylactic Therapy in Healthy Subjects: First, Do No Harm |
| title_fullStr | COVID-19, Clinical Trials, and QT-Prolonging Prophylactic Therapy in Healthy Subjects: First, Do No Harm |
| title_full_unstemmed | COVID-19, Clinical Trials, and QT-Prolonging Prophylactic Therapy in Healthy Subjects: First, Do No Harm |
| title_short | COVID-19, Clinical Trials, and QT-Prolonging Prophylactic Therapy in Healthy Subjects: First, Do No Harm |
| title_sort | covid-19, clinical trials, and qt-prolonging prophylactic therapy in healthy subjects: first, do no harm |
| topic | Article |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7213956/ https://www.ncbi.nlm.nih.gov/pubmed/32407770 http://dx.doi.org/10.1016/j.jacc.2020.05.008 |
| work_keys_str_mv | AT gollobmichaelh covid19clinicaltrialsandqtprolongingprophylactictherapyinhealthysubjectsfirstdonoharm |